TCM
MLTX icon

TCG Crossover Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,000,000
Closed -$10.5M 24
2022
Q4
$10.5M Hold
1,000,000
1.85% 16
2022
Q3
$7.76M Hold
1,000,000
2.33% 14
2022
Q2
$5.25M Buy
+1,000,000
New +$5.25M 2.23% 15